SYDNEY, Tuesday 07 February 2017

Cellmid Limited (ASX: CDY) is pleased to advise that, following the allowance by the US Patent and Trademark Office last week, the European Patent Office has issued Notice of Allowance for the patent application number 11746751.4 entitled “Method of Treatment or Prevention of Hair Loss or for Enhancement of Hair Growth” (midkine or MK alopecia patent). 

Click here to